A Short Review Docking: Structure Based Drug Design

Molecular docking plays a vital role in advancing scientific research, particularly in drug development and understanding biomolecular interactions. This computational approach simulates the binding of small molecules, such as potential drugs, to specific biological targets like proteins or DNA. By predicting the optimal binding configuration and energy, molecular docking helps identify promising drug candidates and sheds light on the underlying mechanisms of biological processes. The accuracy of this method relies heavily on a robust scoring function, which distinguishes between strong and weak binding interactions, enabling the identification of potential medication candidates for validation in experiments. This in-depth review delves into the fundamentals and applications of molecular docking in the realm of drug discovery. It outlines the essential stages of drug design, including structure-based approaches, and explores the intricacies of molecular docking, encompassing various types, underlying principles, and algorithms. The review also examines the critical role of scoring functions in assessing binding affinities and discusses the challenges and limitations inherent in molecular docking. Furthermore, it highlights the significant impact of molecular docking on streamlining drug discovery, making it more efficient and cost-effective. Looking ahead, the review anticipates future advancements in docking algorithms, integration with complementary computational methods, and innovative approaches, which are expected to further augment the capabilities of molecular docking. The primary focus of this review is on the central concept of molecular docking, its diverse interactions, underlying principles, and applications, as well as the challenges, limitations, and available software for molecular docking.